NasdaqCM - Delayed Quote USD

Vivos Therapeutics, Inc. (VVOS)

2.0100

-0.1150

(-5.41%)

At close: May 13 at 4:00 PM EDT

2.0100

0.00

(0.00%)

After hours: May 13 at 7:56 PM EDT

Key Events

Loading Chart for VVOS

9/21 12:03 PM

DELL

Previous Close 2.1250
Open 2.1800
Bid 1.9600 x 100
Ask 2.0700 x 100
Day's Range 1.9700 - 2.2002
52 Week Range 1.9700 - 48.7900
Volume 129,314
Avg. Volume 176,183
Market Cap (intraday) 5.994M
Beta (5Y Monthly) 7.99
PE Ratio (TTM) --
EPS (TTM) -11.1400
Earnings Date Jun 6, 2024 - Jun 10, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 7.22

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

114

Full Time Employees

December 31

Fiscal Year Ends

Sector

Medical Devices

Industry

Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

VVOS

83.84%

S&P 500

9.47%

1-Year Return

VVOS

75.49%

S&P 500

26.61%

3-Year Return

VVOS

98.67%

S&P 500

28.51%

5-Year Return

VVOS

--

S&P 500

42.53%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Vivos Therapeutics, Inc.

2.0100

-5.41%

Mkt Cap 5.994M

Industry Medical Devices

0.1979

-1.05%

Mkt Cap 77.16M

Industry Medical Devices

Bone Biologics Corporation

1.9000

-1.04%

Mkt Cap 1.67M

Industry Medical Devices

INVO Bioscience, Inc.

1.2200

+20.79%

Mkt Cap 4.632M

Industry Medical Devices

NeuroOne Medical Technologies Corporation

1.1500

+1.77%

Mkt Cap 29.821M

Industry Medical Devices

Tivic Health Systems, Inc.

0.4838

-4.22%

Mkt Cap 712,922

Industry Medical Devices

0.2482

-1.63%

Mkt Cap 3.778M

Industry Medical Devices

2.2300

+2.53%

Mkt Cap 44.512M

Industry Medical Devices

Helius Medical Technologies, Inc.

1.6873

+3.52%

Mkt Cap 1.498M

Industry Medical Devices

Aethlon Medical, Inc.

0.9939

-15.77%

Mkt Cap 2.614M

Industry Medical Devices

Hyperfine, Inc.

0.7989

+1.13%

Mkt Cap 57.527M

Industry Medical Devices

Valuation Measures

As of 5/10/2024

Market Cap

6.34M
Enterprise Value

6.69M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

0.19
Price/Book (mrq)

15.42
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

-98.42%
Return on Assets (ttm)

-88.43%
Return on Equity (ttm)

-521.22%
Revenue (ttm)

13.8M
Net Income Avi to Common (ttm)

-13.58M
Diluted EPS (ttm)

-11.1400

Balance Sheet and Cash Flow

Total Cash (mrq)

1.64M
Total Debt/Equity (mrq)

485.40%
Levered Free Cash Flow (ttm)

-7.69M

VVOS does not have Company Insights

ABVC ABVC BioPharma, Inc.

1.0700

+0.94%

RNAZ TransCode Therapeutics, Inc.

0.6162

-56.30%

VRPX Virpax Pharmaceuticals, Inc.

3.0400

+20.16%

ADTX Aditxt, Inc.

2.0600

-1.44%

TPST Tempest Therapeutics, Inc.

3.2800

+0.92%

PALI Palisade Bio, Inc.

6.22

-7.30%

PBLA Panbela Therapeutics, Inc.

0.4061

+6.92%

ENSC Ensysce Biosciences, Inc.

0.5850

+10.65%

NRBO NeuroBo Pharmaceuticals, Inc.

4.0300

+1.77%

NEXI NexImmune, Inc.

3.4100

-3.94%

MINM Minim, Inc.

4.0700

+5.99%

PTPI Petros Pharmaceuticals, Inc.

0.6169

-3.61%

SNOA Sonoma Pharmaceuticals, Inc.

0.1500

+1.49%

SCPS Scopus BioPharma Inc.

0.0011

0.00%

PRFX PainReform Ltd.

0.8200

+4.71%

DBGI Digital Brands Group, Inc.

2.4300

+6.35%